ODYSSEY
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experienced an Acute Coronary Syndrome.
- Stadium
- klaar
- Middel
- alirocumab
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 1 januari 2012
- Last Patient In
- 1 november 2015
- Last Patient Last Visit
- 11 december 2017
Studiedirecteur
